Biotech · Private company · San Diego, CA, US
Sorrento Therapeutics, Inc.
SEC CIK 0000850261
Track this companyFree. Adds Sorrento Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials251 recruiting or active
Pipeline programs26From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline26
- AbirateronePhase 2 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- AbivertinibPhase 2 · Covid-19ClinicalTrials.gov · fetched Nov 12, 2026
- AbivertinibPhase 2 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- COVI-AMGPhase 2 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
- COVI-DROPSPhase 2 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
- COVI-MSCPhase 2 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
- ResiniferatoxinPhase 2 · Osteoarthritis, KneeClinicalTrials.gov · fetched Nov 12, 2026
- ResiniferatoxinPhase 2 · Pain, IntractableClinicalTrials.gov · fetched Nov 12, 2026
- STI-6129Phase 2 · Light Chain (AL) AmyloidosisClinicalTrials.gov · fetched Nov 12, 2026
- STI-6129Phase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- STI-9199Phase 2 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- ZilrettaPhase 2 · Osteoarthritis, KneeClinicalTrials.gov · fetched Nov 12, 2026
- anti-CEA CAR-T cellsPhase 1 · Peritoneal CarcinomatosisClinicalTrials.gov · fetched Nov 12, 2026
- CAR2 Anti-CD38 A2 CAR-T CellsPhase 1 · Relapsed or Refractory Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- CAR2 Anti-CEA CAR-T cellsPhase 1 · Metastatic Pancreatic CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- EnbrelPhase 1 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- Pembrolizumab administered using the Sofusa® DoseConnect™Phase 1 · Mycosis FungoidesClinicalTrials.gov · fetched Nov 12, 2026
- PSC-04Phase 1 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
- ResiniferatoxinPhase 1 · Intractable Cancer PainClinicalTrials.gov · fetched Nov 12, 2026
- Sofusa DoseConnectPhase 1 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- STI-1492Phase 1 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- STI-6129Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- STI-6643Phase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- Sumatriptan Succinate Oral TabletPhase 1 · Migraine DisordersClinicalTrials.gov · fetched Nov 12, 2026
- Transdermal delivery of sumatriptan succinatePhase 1 · Migraine DisordersClinicalTrials.gov · fetched Nov 12, 2026
- Gene-Modified Cell TherapyLong-term Follow-upClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced CancerPHASE2 · SUSPENDED · started Sep 1, 2025ClinicalTrials.gov NCT05067257 · fetched Nov 12, 2026
- Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate CancerPHASE2 · SUSPENDED · started Sep 1, 2025ClinicalTrials.gov NCT05361915 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy of IN STI-9199 in Treating Symptomatic COVID-19 in Outpatient Adults and AdolescentsPHASE2 · WITHDRAWN · started Apr 1, 2023ClinicalTrials.gov NCT05372783 · fetched Nov 12, 2026
- Study to Access Anti-CD38 Anibody Drug in Patients With Advanced Solid TumorsPHASE1 · UNKNOWN · started Mar 1, 2023ClinicalTrials.gov NCT05584709 · fetched Nov 12, 2026
- Study to Assess Anti-CD38 Antibody Drug Conjugate in Relapsed or Refractory Multiple MyelomaPHASE1_PHASE2 · UNKNOWN · started Feb 1, 2023ClinicalTrials.gov NCT05308225 · fetched Nov 12, 2026
- Study to Assess Allogeneic Anti-CD38 A2 Dimeric Antigen Receptor T Cells in Relapsed or Refractory Multiple MyelomaPHASE1 · UNKNOWN · started Oct 1, 2022ClinicalTrials.gov NCT05007418 · fetched Nov 12, 2026
- Pembrolizumab Administered Via the Sofusa® DoseConnect™ in Patients With Relapsed/Refractory Cutaneous T-cell Lymphoma.PHASE1 · UNKNOWN · started Aug 31, 2022ClinicalTrials.gov NCT04118868 · fetched Nov 12, 2026
- Study of the Safety and Efficacy of STI-6643 in Subjects With Advanced Solid TumorsPHASE1 · UNKNOWN · started Nov 24, 2021ClinicalTrials.gov NCT04900519 · fetched Nov 12, 2026
- Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory DistressPHASE2 · UNKNOWN · started Nov 16, 2021ClinicalTrials.gov NCT04905836 · fetched Nov 12, 2026
- Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (US)PHASE2 · COMPLETED · started Nov 16, 2021ClinicalTrials.gov NCT04906694 · fetched Nov 12, 2026
- Study to Evaluate Intra-articular Resiniferatoxin to Treat Moderate to Severe Pain From Knee OsteoarthritisPHASE2 · UNKNOWN · started Nov 15, 2021ClinicalTrials.gov NCT04885972 · fetched Nov 12, 2026
- Long-Term Follow-Up of Patients Who Received Gene-Modified Cell TherapyENROLLING_BY_INVITATION · started Jun 16, 2021ClinicalTrials.gov NCT05472649 · fetched Nov 12, 2026
- Study of the Safety and Efficacy of STI-6129 in Patients With Relapsed or Refractory Systemic AL AmyloidosisPHASE1_PHASE2 · UNKNOWN · started Apr 1, 2021ClinicalTrials.gov NCT04316442 · fetched Nov 12, 2026
- Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Hospitalized Adults With COVID-19PHASE2 · WITHDRAWN · started Apr 1, 2021ClinicalTrials.gov NCT04771351 · fetched Nov 12, 2026
- Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Adults With Mild COVID-19 SymptomsPHASE2 · WITHDRAWN · started Apr 1, 2021ClinicalTrials.gov NCT04734860 · fetched Nov 12, 2026
- Study to Assess the Safety and Efficacy of Enbrel Administered by Sofusa DoseConnect for Rheumatoid ArthritisPHASE1 · UNKNOWN · started Mar 15, 2021ClinicalTrials.gov NCT04559412 · fetched Nov 12, 2026
- Study of Intravenous Administration of Allogeneic Adipose-Derived Mesenchymal Stem Cells for COVID-19-Induced Acute Respiratory DistressPHASE2 · WITHDRAWN · started Mar 1, 2021ClinicalTrials.gov NCT04728698 · fetched Nov 12, 2026
- Study of Intravenous Administration of Allogeneic Adipose Stem Cells for COVID-19PHASE1 · COMPLETED · started Dec 15, 2020ClinicalTrials.gov NCT04486001 · fetched Nov 12, 2026
- Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized With COVID-19PHASE2 · COMPLETED · started Oct 9, 2020ClinicalTrials.gov NCT04440007 · fetched Nov 12, 2026
- Phase 1b Study of CAR2Anti-CEA CAR-T Cell Hepatic Infusions for Pancreatic Carcinoma Patients With CEA+ Liver MetastasesPHASE1 · TERMINATED · started Jul 29, 2019ClinicalTrials.gov NCT03818165 · fetched Nov 12, 2026
- Study to Evaluate the Safety and Efficacy of Anti-CD38 CAR-T in Relapsed or Refractory Multiple Myeloma PatientsPHASE1 · COMPLETED · started Oct 15, 2018ClinicalTrials.gov NCT03464916 · fetched Nov 12, 2026
- CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC)PHASE1 · WITHDRAWN · started Sep 13, 2018ClinicalTrials.gov NCT03682744 · fetched Nov 12, 2026
- Study of Resiniferatoxin for Knee Pain in Moderate to Severe OsteoarthritisPHASE1 · COMPLETED · started Jul 12, 2018ClinicalTrials.gov NCT03542838 · fetched Nov 12, 2026
- Sofusa System With Sumatriptan (KC5010) Phase 1 Dose Escalation Safety and PK Study (KCC-SMT-002)PHASE1 · COMPLETED · started Jan 17, 2018ClinicalTrials.gov NCT03229798 · fetched Nov 12, 2026
- Study to Evaluate Safety and MTD of Epidural Resiniferatoxin Injection for Treatment of Intractable Cancer PainPHASE1 · COMPLETED · started Sep 1, 2017ClinicalTrials.gov NCT03226574 · fetched Nov 12, 2026